Pages that link to "Q36136157"
Jump to navigation
Jump to search
The following pages link to Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status (Q36136157):
Displaying 50 items.
- A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy (Q24538802) (← links)
- p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy (Q24650994) (← links)
- Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer (Q24793291) (← links)
- Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination (Q24793366) (← links)
- Cyclins and breast cancer (Q33538420) (← links)
- Cell cycle regulators and their abnormalities in breast cancer (Q33588357) (← links)
- siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model (Q33705021) (← links)
- Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States (Q33748595) (← links)
- Novel splice variants of cyclin E with altered substrate specificity (Q33855990) (← links)
- PKCalpha expression is a marker for breast cancer aggressiveness (Q33864132) (← links)
- Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance (Q33903965) (← links)
- Expression of cyclins E1 and E2 during mouse development and in neoplasia (Q33949158) (← links)
- Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas (Q33951820) (← links)
- ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency (Q33963261) (← links)
- Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function (Q33967106) (← links)
- Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms (Q33969505) (← links)
- Overexpression of POLQ confers a poor prognosis in early breast cancer patients (Q34051213) (← links)
- Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas (Q34293438) (← links)
- Estrogens and cell-cycle regulation in breast cancer (Q34336956) (← links)
- Cyclin E in normal and neoplastic cell cycles (Q34412356) (← links)
- A working model for the time sequence of genetic changes in breast tumorigenesis (Q34534165) (← links)
- Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis (Q34554750) (← links)
- Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines (Q34604712) (← links)
- Msx-1 and Msx-2 in mammary gland development (Q35858263) (← links)
- Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? (Q36175746) (← links)
- The therapeutic potential of targeting the cell cycle (Q36181206) (← links)
- Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer (Q36431462) (← links)
- Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas (Q36497940) (← links)
- Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer (Q36604034) (← links)
- Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors (Q36641897) (← links)
- Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors (Q36998212) (← links)
- CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer (Q37149363) (← links)
- A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2. (Q38296317) (← links)
- The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with int (Q38450339) (← links)
- Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer (Q38452330) (← links)
- Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells. (Q38692982) (← links)
- A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. (Q38708251) (← links)
- A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity (Q39381631) (← links)
- Aberrant expression of cyclin E in low-risk node negative breast cancer (Q39852495) (← links)
- Novel role for cyclin-dependent kinase 2 in neuregulin-induced acetylcholine receptor epsilon subunit expression in differentiated myotubes (Q40436456) (← links)
- The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27. (Q40459035) (← links)
- High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells. (Q40462506) (← links)
- AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. (Q40481763) (← links)
- Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. (Q40602827) (← links)
- Overexpression of cyclin E does not influence homologous recombination in Chinese hamster cells (Q40712853) (← links)
- The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node (Q40720961) (← links)
- Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts (Q42028372) (← links)
- Effects of bisphenol compounds on the growth and epithelial mesenchymal transition of MCF-7 CV human breast cancer cells (Q42343605) (← links)
- Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes (Q43498905) (← links)
- Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma (Q43572717) (← links)